Guide: How Connected Devices Improve Clinical Trial Data

Since 2020, the adoption of connected devices in clinical trials has surged significantly. This trend is driven by the need for more efficient and accurate data collection, leading sponsors and CROs to invest heavily in devices that enhance remote monitoring capabilities and patient engagement. Wearables, sensors, and mobile apps are revolutionizing clinical trial processes by enabling real-time data collection and providing deeper insights into patient behavior and treatment outcomes.

A report by Grand View Research predicts that the global connected device analytics market in healthcare will grow at an impressive compound annual growth rate (CAGR) of 28.9% from 2022 to 2030. This growth is fueled by the increasing demand for real-world evidence, the necessity for remote patient monitoring, and a greater focus on value-based care models.

Connected devices offer numerous advantages in clinical trials, such as continuous data collection, reduced patient burden, and improved adherence to study protocols. By utilizing these devices, researchers can monitor participants' vital signs, activity levels, and other relevant parameters without requiring frequent on-site visits, thereby enhancing the efficiency and quality of data collection.